Compare Cassava Sciences Inc (FLNA) vs Yum China Holdings Inc (YUMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Yum China Holdings Inc — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while Yum China Holdings Inc trades at $44.25 (market cap $14.84B). The key difference: Yum China Holdings Inc is far larger — about 279.3× Cassava Sciences Inc's market cap, and Yum China Holdings Inc pays a 2.69% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | YUMC | |
|---|---|---|
Market Cap | $53.14M | $14.84B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.64 | $57.95 |
52-Week Low | $1.09 | $40.18 |
Enterprise Value | -$33.43M | $15.73B |
Dividend Yield | — | 2.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
YUMC trades at $44.42, up 2.58% today, with a bullish technical signal and strong fundamental performance. The stock shows consistent earnings beats, with Q1 2026 EPS of $0.87 exceeding expectations, and maintains solid profitability with a 7.83% net income margin. Recent developments include the acquisition of Pizza Hut's mainland China operations and a $512 million share repurchase plan for H2 2026, signaling management confidence and shareholder returns.
Outlook remains positive due to steady revenue growth, expanding store footprint, and aggressive capital returns, but risks include Chinese consumer spending volatility and integration challenges from the Pizza Hut acquisition. Analyst consensus strongly favors buying, with 74% buy ratings, supporting a constructive view for long-term investors despite near-term macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Yum China Holdings Inc
With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
Read more on YUMC →
